Concepedia

Preemptive Plerixafor Use

Preemptive Plerixafor Use is a clinical strategy in stem cell mobilization wherein the administration of plerixafor is initiated based on predictive risk factors or early mobilization response indicators prior to confirmed mobilization failure, distinguishing it from reactive use by enabling earlier intervention to enhance hematopoietic stem cell yield.

22

Publications

756

Citations

201

Authors

96

Institutions

Publications per year

2017–2026

3

Parents

Publications

22

A risk-based approach to optimize autologous hematopoietic stem cell (HSC) collection with the use of plerixafor

Sunil Abhyankar, Shaun DeJarnette, Omar S. Aljitawi et al. · Bone Marrow Transplantation · 2011 · 88 citations

, , +13

Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program

Kai Hübel, Maximilian M. Fresen, Hans Salwender et al. · Bone Marrow Transplantation · 2010 · 79 citations

, , +11

Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience

Cedar Fowler, A. Dunn, B. Hayes-Lattin et al. · Bone Marrow Transplantation · 2009 · 72 citations

, , +13

Efficacy and cost‐benefit analysis of risk‐adaptive use of plerixafor for autologous hematopoietic progenitor cell mobilization

Prakash Vishnu, Vivek Roy, Athena Paulsen et al. · Transfusion · 2011 · 56 citations

, , +17

Growth factor plus preemptive (‘just-in-time’) plerixafor successfully mobilizes hematopoietic stem cells in multiple myeloma patients despite prior lenalidomide exposure

Luciano J. Costa, Jonathan Abbas, Kathy R. Hogan et al. · Bone Marrow Transplantation · 2012 · 53 citations

, , +17

1–5 of 22

Authors

201

  1. TK
    Taru Kuittinen

    Kuopio University Hospital, Finland

    3 publications · 82 citations

    3

    h-index

  2. FA
    Fevzi Altuntaş

    Erciyes University, Türkiye

    2 publications · 24 citations

    2

    h-index

  3. RT
    Richard T. Maziarz

    Oregon Health & Science University, United States

    2 publications · 105 citations

    2

    h-index

  4. EM
    Eija Mahlamäki

    Kuopio University Hospital, Finland

    2 publications · 52 citations

    2

    h-index

  5. KB
    Katie B Shoptaw

    Medical University of South Carolina, United States

    2 publications · 85 citations

    2

    h-index

1–5 of 201

Institutions

96

  1. Eastern Finland Laboratory Center

    Kuopio, Finland

    3 h-index

    4 publications

    110 citations

  2. Kuopio University Hospital

    Kuopio, Finland

    3 h-index

    13 publications

    352 citations

  3. Oregon Health & Science University

    Portland, United States

    2 h-index

    16 publications

    801 citations

  4. Ankara University

    Ankara, Türkiye

    2 h-index

    4 publications

    46 citations

  5. Medical University of South Carolina

    Charleston, United States

    2 h-index

    18 publications

    786 citations

  6. University of Eastern Finland

    Joensuu, Finland

    2 h-index

    3 publications

    86 citations

  7. The Ohio State University

    Columbus, United States

    1 h-index

    1 publications

    14 citations

  8. New York Blood Center

    New York, United States

    1 h-index

    1 publications

    16 citations

1–8 of 96

Venues

  1. Bone Marrow Transplantation

    9 publications · 454 citations

    9

    h-index

  2. Transfusion

    4 publications · 134 citations

    4

    h-index

  3. Leukemia Research

    2 publications · 29 citations

    2

    h-index

  4. Clinical Lymphoma Myeloma & Leukemia

    1 publications · 20 citations

    1

    h-index

  5. Cytotherapy

    1 publications · 33 citations

    1

    h-index

1–5